Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep LearningCell, 2018-02, Vol.172 (5), p.1122-1131.e9 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2018.02.010 ;PMID: 29474911Full text available |
2 |
Material Type: Article
|
![]() |
Pathogenesis of diabetic macular edema: role of the glial factor (literature review and own data)Miz︠h︡narodnyĭ endokrynolohichnyĭ z︠h︡urnal, 2023-10, Vol.19 (6), p.433-437 [Peer Reviewed Journal]ISSN: 2224-0721 ;EISSN: 2307-1427 ;DOI: 10.22141/2224-0721.19.6.2023.1312Full text available |
3 |
Material Type: Article
|
![]() |
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision lossEye and vision (Novato, Calif.), 2015-01, Vol.2 (1), p.17-17, Article 17 [Peer Reviewed Journal]Copyright BioMed Central 2015 ;Lee et al. 2015 ;ISSN: 2326-0254 ;ISSN: 2326-0246 ;EISSN: 2326-0254 ;DOI: 10.1186/s40662-015-0026-2 ;PMID: 26605370Full text available |
4 |
Material Type: Article
|
![]() |
Angiogenesis and Inflammation Crosstalk in Diabetic RetinopathyJournal of cellular biochemistry, 2016-11, Vol.117 (11), p.2443-2453 [Peer Reviewed Journal]2016 Wiley Periodicals, Inc. ;ISSN: 0730-2312 ;EISSN: 1097-4644 ;DOI: 10.1002/jcb.25575 ;PMID: 27128219Full text available |
5 |
Material Type: Article
|
![]() |
Comparison of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by Optical Coherence TomographyEgyptian Journal of Medical Research, 2022-04, Vol.3 (2), p.226-242 [Peer Reviewed Journal]ISSN: 2682-4396 ;EISSN: 2682-440X ;DOI: 10.21608/ejmr.2022.240903Full text available |
6 |
Material Type: Article
|
![]() |
Deep Learning Predicts OCT Measures of Diabetic Macular Thickening From Color Fundus PhotographsInvestigative ophthalmology & visual science, 2019-03, Vol.60 (4), p.852-857 [Peer Reviewed Journal]ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.18-25634 ;PMID: 30821810Full text available |
7 |
Material Type: Article
|
![]() |
Effect of aflibercept combined with triamcinolone acetonide on aqueous humor growth factor and inflammatory mediators in diabetic macular edemaInternational journal of ophthalmology, 2024-02, Vol.17 (2), p.297-303 [Peer Reviewed Journal]International Journal of Ophthalmology Press. ;International Journal of Ophthalmology Press 2024 ;ISSN: 2222-3959 ;EISSN: 2227-4898 ;DOI: 10.18240/ijo.2024.02.11 ;PMID: 38371257Full text available |
8 |
Material Type: Article
|
![]() |
Evaluation Of Choroidal Thickness Before and After Intravitreal Injection Of Anti Vascular endothelial growth factors for Treatment Of Diabetic Macular Edema using Optical Coherence TomographySVU - International Journal of Medical Sciences (Online), 2023-07, Vol.6 (2), p.841-850 [Peer Reviewed Journal]ISSN: 2636-3402 ;ISSN: 2735-427X ;EISSN: 2636-3402 ;DOI: 10.21608/svuijm.2023.194461.1528Full text available |
9 |
Material Type: Article
|
![]() |
Diabetic Macular Edema Outcomes in Eyes Treated with Fluocinolone Acetonide 0.2 µg/d Intravitreal Implant: Real-World UK ExperienceEuropean journal of ophthalmology, 2017-05, Vol.27 (3), p.357-362 [Peer Reviewed Journal]2017 SAGE Publications ;ISSN: 1120-6721 ;EISSN: 1724-6016 ;DOI: 10.5301/ejo.5000929Digital Resources/Online E-Resources |
10 |
Material Type: Article
|
![]() |
Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular EdemaInvestigative ophthalmology & visual science, 2019-04, Vol.60 (5), p.1336-1343 [Peer Reviewed Journal]ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.18-26215 ;PMID: 30933261Full text available |
11 |
Material Type: Article
|
![]() |
Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative ApproachInvestigative ophthalmology & visual science, 2017-05, Vol.58 (6), p.BIO68-BIO75 [Peer Reviewed Journal]ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-21769 ;PMID: 28510630Full text available |
12 |
Material Type: Article
|
![]() |
Research progress of Mingmu-11 and its active ingredients for the treatment of diabetic macular edemaGuo ji yan ke za zhi, 2022-12, Vol.22 (12), p.1987-1991 [Peer Reviewed Journal]ISSN: 1672-5123 ;DOI: 10.3980/j.issn.1672-5123.2022.12.10Full text available |
13 |
Material Type: Article
|
![]() |
Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical TrialJournal of ophthalmic & vision research, 2024-01, Vol.19 (1), p.25-32 [Peer Reviewed Journal]Copyright © 2024 Ramezani et al. ;Copyright © 2024 Ramezani et al. 2024 ;ISSN: 2008-2010 ;EISSN: 2008-322X ;DOI: 10.18502/jovr.v19i1.15424 ;PMID: 38638629Full text available |
14 |
Material Type: Article
|
![]() |
Anti-VEGF combined with ocular corticosteroids therapy versus anti-VEGF monotherapy for diabetic macular edema focusing on drugs injection times and confounding factors of pseudophakic eyes: A systematic review and meta-analysisPharmacological research, 2023-10, Vol.196, p.106904 [Peer Reviewed Journal]EISSN: 1096-1186 ;DOI: 10.1016/j.phrs.2023.106904Digital Resources/Online E-Resources |
15 |
Material Type: Article
|
![]() |
Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathyAsia-Pacific journal of ophthalmology (Philadelphia, Pa.), 2024-05, p.100067-100067, Article 100067 [Peer Reviewed Journal]2024 The Authors ;Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 2162-0989 ;EISSN: 2162-0989 ;DOI: 10.1016/j.apjo.2024.100067 ;PMID: 38750958Full text available |
16 |
Material Type: Article
|
![]() |
Genetic Association of TIE2 with Diabetic Retinopathy and Diabetic Macular EdemaAsia-Pacific journal of ophthalmology (Philadelphia, Pa.), 2024-05, p.100068-100068 [Peer Reviewed Journal]Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 2162-0989 ;DOI: 10.1016/j.apjo.2024.100068 ;PMID: 38750959Full text available |
17 |
Material Type: Article
|
![]() |
Comparison between the Effect of Aflibercept (Eylea) and Ranibizumab (Lucentis) on Intraocular Pressure after 3rd Injection in Treatment of Diabetic Macular EdemaEgyptian Journal of Medical Research, 2022-07, Vol.3 (3), p.130-145 [Peer Reviewed Journal]ISSN: 2682-4396 ;EISSN: 2682-440X ;DOI: 10.21608/ejmr.2022.255022Full text available |
18 |
Material Type: Article
|
![]() |
A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular EdemaInvestigative ophthalmology & visual science, 2018-05, Vol.59 (6), p.2659-2669 [Peer Reviewed Journal]ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-22731 ;PMID: 29847672Full text available |
19 |
Material Type: Article
|
![]() |
Fully automated detection of retinal disorders by image-based deep learningGraefe's archive for clinical and experimental ophthalmology, 2019-03, Vol.257 (3), p.495-505 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;Graefe's Archive for Clinical and Experimental Ophthalmology is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-018-04224-8 ;PMID: 30610422Full text available |
20 |
Material Type: Article
|
![]() |
Visual function and visual quality in diabetic macular edema treated by ConberceptGuo ji yan ke za zhi, 2022-01, Vol.22 (1), p.127-129 [Peer Reviewed Journal]ISSN: 1672-5123 ;DOI: 10.3980/j.issn.1672-5123.2022.1.28Full text available |